Probiotics: A potential immunomodulator in COVID-19 infection management

COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the human respiratory tract's epithelial cells, leading to a proinflammatory cytokine storm and chronic lung inflammation. With numerous patients dying daily, a vaccine and specific antiviral drug regimens are being...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kuljit, Rao, Alka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881295/
https://www.ncbi.nlm.nih.gov/pubmed/33592454
http://dx.doi.org/10.1016/j.nutres.2020.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881295/
https://www.ncbi.nlm.nih.gov/pubmed/33592454
http://dx.doi.org/10.1016/j.nutres.2020.12.014

Ejemplares similares